N-methyl-D-aspartate receptor glycine site (NMDA receptor glycine site)

The N-methyl-D-aspartate receptor glycine site is a co-agonist binding site located on the NMDA receptor, an ionotropic glutamate receptor that functions as a ligand-gated ion channel. Activation of the NMDA receptor requires simultaneous binding of glutamate to its site (on GluN2 subunits) and either glycine or D-serine to this glycine site (on GluN1 or GluN3 subunits). Glycine-site occupancy is essential for channel opening, calcium influx, and subsequent signaling crucial for synaptic plasticity, learning, and memory formation. The glycine site is a focus of pharmacological intervention—both direct agonists and indirect modulators (e.g., GlyT1 and DAO inhibitors) are studied as treatments for schizophrenia, depression, and other neuropsychiatric disorders. Therapeutic targeting of the glycine site requires consideration of endogenous ligand concentrations and subtype-specific receptor affinities to avoid overstimulation or excitotoxicity. The site’s regulation is also implicated in disease pathogenesis, synapse maturation, and neurodevelopmental processes.

Other names

Glycine modulatory site of NMDA receptorGMSNMDA-r glycine siteNMDA receptor co-agonist site

Agonists increase glycine (or D-serine) occupancy, enhancing NMDA receptor function GlyT1 inhibitors raise synaptic glycine concentration, indirectly stimulating NMDA receptor activity DAO inhibitors increase D-serine availability, indirectly activating the glycine site Competitive antagonists block co-agonist binding, reducing receptor activation